John W. Higuchi's most recent trade in Lipocine Inc was a trade of 1,764 Common Stock (Right to Buy) done . Disclosure was reported to the exchange on June 4, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Lipocine Inc | John W. Higuchi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 1,764 | 11,526 | - | - | Common Stock (Right to Buy) | |
| Lipocine Inc | John W. Higuchi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 1,764 | 10,938 | - | - | Common Stock (Right to Buy) | |
| Lipocine Inc | John W. Higuchi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2023 | 30,000 | 156,000 | - | - | Common Stock (Right to Buy) | |
| Lipocine Inc | John W. Higuchi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 22,000 | 307,490 | - | - | Common Stock (Right to Buy) | |
| Lipocine Inc | John W. Higuchi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2021 | 22,000 | 22,000 | - | - | Common Stock (Right to Buy) | |
| Lipocine Inc | John W. Higuchi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Dec 2020 | 3,750 | 700,248 (1%) | 0% | 0 | Common Stock | |
| Lipocine Inc | John W. Higuchi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Dec 2020 | 3,750 | 3,750 | - | - | Restricted Stock Unit |